The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Multilevel Dysregulation of STAT3 Activation in Anaplastic Lymphoma Kinase-Positive T/Null-Cell Lymphoma
Abstract
Accumulating evidence indicates that expression of anaplastic lymphoma kinase (ALK), typically due to t(2;5) translocation, defines a distinct type of T/null-cell lymphoma (TCL). The resulting nucleophosmin (NPM) /ALK chimeric kinase is constitutively active and oncogenic. Downstream effector molecules triggered by NPM/ALK remain, however, largely unidentified. Here we report that NPM/ALK induces continuous activation of STAT3. STAT3 displayed tyrosine phosphorylation and DNA binding in all (four of four) ALK+ TCL cell lines tested. The activation of STAT3 was selective because none of the other known STATs was consistently tyrosine phosphorylated in these cell lines. In addition, malignant cells in tissue sections from all (10 of 10) ALK+ TCL patients expressed tyrosine-phosphorylated STAT3. Transfection of BaF3 cells with NPM/ALK resulted in tyrosine phosphorylation of STAT3. Furthermore, STAT3 was constitutively associated with NPM/ALK in the ALK+ TCL cell lines. Additional studies into the mechanisms of STAT3 activation revealed that the ALK+ TCL cells expressed a positive regulator of STAT3 activation, protein phosphatase 2A (PP2A), which was constitutively associated with STAT3. Treatment with the PP2A inhibitor calyculin A abrogated tyrosine phosphorylation of STAT3. Finally, ALK+ T cells failed to express a negative regulator of activated STAT3, protein inhibitor of activated STAT3. These data indicate that NPM/ALK activates STAT3 and that PP2A and lack of protein inhibitor of activated STAT3 may be important in maintaining STAT3 in the activated state in the ALK+ TCL cells. These results also suggest that activated STAT3, which is known to display oncogenic properties, as well as its regulatory molecules may represent attractive targets for novel therapies in ALK+ TCL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R., & Talpaz, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441402 · Cited by 2,713
Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K. G., Shapiro, D. N., Saltman, D. L., & Look, A. T. (1994) · Science · doi:10.1126/science.8122112 · Cited by 2,409
Self-citationJAKS AND STATS: Biological Implications
Leonard, W. J., & O'Shea, J. J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.293 · Cited by 1,804
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
Tyrosine Kinase Inhibition: An Approach to Drug Development
Levitzki, A., & Gazit, A. (1995) · Science · doi:10.1126/science.7892601 · Cited by 1,635
Major nucleolar proteins shuttle between nucleus and cytoplasm
Borer, R. A., Lehner, C. F., Eppenberger, H. M., & Nigg, E. A. (1989) · Cell · doi:10.1016/0092-8674(89)90241-9 · Cited by 1,114
Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Müller, M., Druker, B. J., & Lydon, N. (1996) · PubMed · Cited by 1,057
Specific Inhibition of Stat3 Signal Transduction by PIAS3
Chung, C. D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P., & Shuai, K. (1997) · Science · doi:10.1126/science.278.5344.1803 · Cited by 980
Inhibition of Stat1-mediated gene activation by PIAS1
Liu, B., Liao, J., Rao, X., Kushner, S. A., Chung, C. D., Chang, D. D., & Shuai, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10626 · Cited by 765
Iwahara, T., Fujimoto, J., Wen, D., Cupples, R., Bucay, N., Arakawa, T., Mori, S., Ratzkin, B., & Yamamoto, T. (1997) · Oncogene · doi:10.1038/sj.onc.1200849 · Cited by 726
Druker, B. J., & Lydon, N. B. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9083 · Cited by 707
Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation
Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., De Groot, R. P., & Jove, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2545 · Cited by 651
Stat3 Activation Is Required for Cellular Transformation by v- src
Bromberg, J. F., Horvath, C. M., Besser, D., Lathem, W. W., & Darnell, J. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2553 · Cited by 614
Mechanism-Based Target Identification and Drug Discovery in Cancer Research
Gibbs, J. B. (2000) · Science · doi:10.1126/science.287.5460.1969 · Cited by 606
Grandis, J. R., Drenning, S. D., Zeng, Q., Watkins, S. C., Melhem, M. F., Endo, S., Johnson, D. E., Huang, L., He, Y., & Kim, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4227 · Cited by 588
ALK+ lymphoma: clinico-pathological findings and outcome.
Falini, B., Pileri, S. A., Zinzani, P. L., Carbone, A., Zagonel, V., Wolf‐Peeters, C. D., Verhoef, G. E. G., Menestrina, F., Todeschini, G., Paulli, M., et al. (1999) · PubMed · doi:10.1182/blood.v93.8.2697 · Cited by 560
Pulford, K. A. F., Lamant, L., Morris, S. W., Butler, L. H., Wood, K. M., Stroud, D., Delsol, G., & Mason, D. Y. (1997) · Blood · doi:10.1182/blood.v89.4.1394 · Cited by 557
Self-citationConstitutively activated Jak-STAT pathway in T cells transformed with HTLV-I
Migone, T.-S., Lin, J.-X., Cereseto, A., Mulloy, J. C., O'Shea, J. J., Franchini, G., & Leonard, W. J. (1995) · Science · doi:10.1126/science.7604283 · Cited by 557
Gascoyne, R. D., Aoun, P., Wu, D., Chhanabhai, M., Skinnider, B. F., Greiner, T. C., Morris, S. W., Connors, J. M., Vose, J. M., Viswanatha, D. S., et al. (1999) · Blood · doi:10.1182/blood.v93.11.3913 · Cited by 524
Self-citationMorris, S. W., Naeve, C., Mathew, P., James, P. L., Kirstein, M. N., Cui, X., & Witte, D. P. (1997) · Oncogene · doi:10.1038/sj.onc.1201062 · Cited by 524
Self-citationle Coutre, P., Tassi, E., Varella-Garcia, M., Barni, R., Mologni, L., Cabrita, G., Marchesi, E., Supino, R., & Gambacorti-Passerini, C. (2000) · Blood · doi:10.1182/blood.v95.5.1758.005a41_1758_1766 · Cited by 484
Weisberg, E., & Griffin, J. D. (2000) · Blood · doi:10.1182/blood.v95.11.3498 · Cited by 401
Shiota, M., Nakamura, S., Ichinohasama, R., Abe, M., Akagi, T., Takeshita, M., Mori, N., Fujimoto, J., Miyauchi, J., & Mikata, A. (1995) · Blood · doi:10.1182/blood.v86.5.1954.bloodjournal8651954 · Cited by 380
Bischof, D., Pulford, K., Mason, D. Y., & Morris, S. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2312 · Cited by 363
Self-citationBai, R.-Y., Ouyang, T., Miething, C., Morris, S. W., Peschel, C., & Duyster, J. (2000) · Blood · doi:10.1182/blood.v96.13.4319 · Cited by 319
Self-citationFujimoto, J., Shiota, M., Iwahara, T., Seki, N., Satoh, H., Mori, S., & Yamamoto, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4181 · Cited by 289
Hernández, L., Pinyol, M., Hernández, S., Beà, S., Pulford, K., Rosenwald, A., Lamant, L., Falini, B., Ott, G., Mason, D. Y., et al. (1999) · Blood · doi:10.1182/blood.v94.9.3265 · Cited by 287
Bai, R.-Y., Dieter, P., Peschel, C., Morris, S. W., & Duyster, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.6951 · Cited by 281
Self-citationFalini, B., Bigerna, B., Fizzotti, M., Pulford, K., Pileri, S. A., Delsol, G., Carbone, A., Paulli, M., Magrini, U., Menestrina, F., et al. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65629-5 · Cited by 276
Nieborowska-Skorska, M., Wasik, M. A., Slupianek, A., Salomoni, P., Kitamura, T., Calabretta, B., & Skorski, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1229 · Cited by 271
Self-citationChan, W. Y., Liu, Q. R., Borjigin, J., Busch, H., Rennert, O. M., Tease, L. A., & Chan, P. K. (1989) · Biochemistry · doi:10.1021/bi00429a017 · Cited by 270
Słupianek, A., Nieborowska-Skorska, M., Hoser, G., Morrione, A., Majewski, M., Xue, L., Morris, S. W., Wasik, M. A., & Skórski, T. (2001) · PubMed · Cited by 258
Self-citationShiota, M., Fujimoto, J., Semba, T., Satoh, H., Yamamoto, T. S., & Mori, S. (1994) · PubMed · Cited by 246
Zhang, Q., Nowak, I., Vonderheid, E. C., Rook, A. H., Kadin, M. E., Nowell, P. C., Shaw, L. M., & Wasik, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9148 · Cited by 221
Self-citationNielsen, M., Kaltoft, K., Nordahl, M., Röpke, C., Geisler, C., Mustelin, T., Dobson, P., Svejgaard, A., & Ødum, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6764 · Cited by 220
Self-citationLymphomas expressing ALK fusion protein(s) other than NPM-ALK.
Falini, B., Pulford, K. A. F., Pucciarini, A., Carbone, A., Wolf‐Peeters, C. D., Cordell, J., Fizzotti, M., Santucci, A., Pelicci, P. G., Pileri, S. A., et al. (1999) · PubMed · doi:10.1182/blood.v94.10.3509.422k36_3509_3515 · Cited by 210
Majewski, M., Korecka, M., Kossev, P., Li, S., Goldman, J., Moore, J., Silberstein, L. E., Nowell, P. C., Schuler, W., Shaw, L. M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080068597 · Cited by 210
Self-citationNielsen, M., Kæstel, C., Eriksen, K., Woetmann, A., Stokkedal, T., Kaltoft, K., Geisler, C., Röpke, C., & Ødum, N. (1999) · Leukemia · doi:10.1038/sj.leu.2401415 · Cited by 197
Colleoni, G. W. B., Bridge, J. A., Garicochea, B., Liu, J., Filippa, D. A., & Ladanyi, M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64945-0 · Cited by 174
Studies of IFN-Induced Transcriptional Activation Uncover the Jak-Stat Pathway
DARNELL, J. E. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.549 · Cited by 170
Interaction of nucleolar phosphoprotein B23 with nucleic acids
Dumbar, T. S., Gentry, G. A., & Olson, M. O. J. (1989) · Biochemistry · doi:10.1021/bi00450a037 · Cited by 161
LEUKOCYTE PROTEIN TYROSINE KINASES:Potential Targets for Drug Discovery
Bolen, J. B., & Brugge, J. S. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.371 · Cited by 143
Zhang, Q., Raghunath, P. N., Vonderheid, E. C., Ødum, N., & Wasik, M. A. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64629-9 · Cited by 142
Self-citationDeininger, M. W., Vieira, S., Mendiola, R., Schultheis, B. S., Goldman, J. M., & Melo, J. V. (2000) · PubMed · Cited by 137
Downing, J. R., Shurtleff, S., Zieleńska, M., Curcio-Brint, A., Behm, F., Head, D., Sandlund, J. T., Weisenburger, D., Kossakowska, A., & Thorner, P. S. (1995) · Blood · doi:10.1182/blood.v85.12.3416.bloodjournal85123416 · Cited by 136
Woetmann, A., Nielsen, M., Christensen, S. T., Brockdorff, J. L., Kaltoft, K., Engel, A., Skov, S., Brender, C., Geisler, C., Svejgaard, A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10620 · Cited by 133
STAT Signaling in the Pathogenesis and Treatment of Cancer
Frank, D. A. (1999) · Molecular Medicine · doi:10.1007/bf03403538 · Cited by 125
Xu, X., Kang, S. H., Heidenreich, O. T., Okerholm, M., O’Shea, J. J., & Nerenberg, M. I. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118193 · Cited by 112
Stat3-Mediated Transformation of NIH-3T3 Cells by the Constitutively Active Q205L Gα o Protein
Ram, P. T., Horvath, C. M., & Iyengar, R. (2000) · Science · doi:10.1126/science.287.5450.142 · Cited by 109
The role of STATs in proliferation, differentiation, and apoptosis
Mui, A. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050394 · Cited by 106
The NPM-ALK and the ATIC-ALK Fusion Genes Can Be Detected in Non-Neoplastic Cells
Maes, B., Vanhentenrijk, V., Włodarska, I., Cools, J., Peeters, B., Marynen, P., & Wolf‐Peeters, C. D. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64690-1 · Cited by 101
The STAT family of proteins in cytokine signaling.
Shuai, K. (1999) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(98)00051-0 · Cited by 95
Nielsin, M. (1997) · Proceedings of the National Academy of Sciences · Cited by 93
Wellmann, A., Doseeva, V., Butscher, W. G., Raffeld, M. A., Fukushima, P. I., Stetler‐Stevenson, M., & Gardner, K. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.12.9337149 · Cited by 69
Kadin, M. E., & Morris, S. W. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809068562 · Cited by 65
Self-citationSiebert, R., Gesk, S., Harder, L., et al. (1999) · PubMed · doi:10.1182/blood.v94.10.3614.422a38e_3614_3617 · Cited by 49
Protein Phosphorylation and Dephosphorylation in Physiologic and Oncologic Processes
Patarca, R. (1996) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v7.i5-6.20 · Cited by 39
Zhang, Q., Lee, B., Korecka, M., Li, G., Weyland, C., Eck, S., Gessain, A., Arima, N., Lessin, S. R., Shaw, L. M. J., et al. (1999) · Leukemia Research · doi:10.1016/s0145-2126(98)00173-8 · Cited by 35
Self-citationDirks, W. G., Zaborski, M., Jäger, K., Challier, C., Shiota, M., Quentmeier, H., & Drexler, H. G. (1996) · PubMed · Cited by 27
Cited by
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Transcription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells
Rush, J., Moritz, A., Lee, K. A., Guo, A., Goss, V. L., Spek, E. J., Zhang, H., Zha, X.-M., Polakiewicz, R. D., & Comb, M. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1046 · Cited by 1,124
The anaplastic lymphoma kinase in the pathogenesis of cancer
Chiarle, R., Voena, C., Ambrogio, C., Piva, R., & Inghirami, G. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2291 · Cited by 882
Metadata
- Authors
- Zhang, Q., Raghunath, P. N., Xue, L., Majewski, M., Carpentieri, D. F., Odum, N., Morris, S., Skorski, T., & Wasik, M. A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-01-01
- Volume
- 168
- Issue
- 1
- Pages
- 466-474
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2162082382
- Cited by
- 262
- References
- 62
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.